Immunogenomics Analysis Reveals that TP53 Mutations Inhibit Tumor Immunity in Gastric Cancer()

Although immunotherapy continues to demonstrate efficacy in a variety of refractory cancers, currently, no any immunotherapeutic strategy is clinically used for gastric cancer (GC) except its microsatellite instable subtype. Thus, it is important to identify molecular biomarkers for predicting the r...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Transl Oncol
Asıl Yazarlar: Jiang, Zehang, Liu, Zhixian, Li, Mengyuan, Chen, Cai, Wang, Xiaosheng
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Neoplasia Press 2018
Konular:
Original article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6078052/
https://ncbi.nlm.nih.gov/pubmed/30059832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2018.07.012
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller